Login / Signup

Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.

Rémi GalvesAntoine Da CostaRomain PierrardGeoffrey BayardJean Baptiste GuichardKarl Isaaz
Published in: Echocardiography (Mount Kisco, N.Y.) (2020)
In HFrEF pts, β-blocker therapy significantly improves LV and RV systolic remodeling. Accordingly, β-blocker therapy could be applied as soon as possible in HFrEF patients with right ventricular dysfunction so as to limit RV remodeling.
Keyphrases
  • mycobacterium tuberculosis
  • heart failure
  • blood pressure
  • angiotensin converting enzyme
  • oxidative stress
  • stem cells
  • angiotensin ii
  • ejection fraction
  • atrial fibrillation
  • cell therapy